Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free BMEA Stock Alerts

Biomea Fusion (BMEA) News Today

Biomea Fusion logo
$1.72 +0.13 (+7.86%)
As of 02:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Biomea Fusion Latest News

Biomea Shares Rise After Completing Enrollment in Diabetes Trial
August 24 at 10:06 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/biomea-shares-rise-completing-enrollment-184756479.html
Biomea Fusion Target of Unusually High Options Trading (NASDAQ:BMEA)
August 24 at 10:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/biomea-fusion-target-of-unusually-high-options-trading-nasdaqbmea-2026-08-24/
Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
August 24 at 7:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/24/3349612/0/en/biomea-fusion-announces-completion-of-enrollment-in-covalent-211-phase-ii-trial-of-icovamenib-in-insulin-deficient-type-2-diabetes.html
Biomea Fusion Inc BMEA
August 15, 2026  |  morningstar.comM
Biomea Fusion Initiates OPAL Study Arm of Icovamenib Plus Low-Dose Semaglutide in Obesity Research
August 13, 2026  |  quiverquant.comQ
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344342/0/en/biomea-fusion-announces-first-patient-dosed-in-opal-study-evaluating-icovamenib-in-combination-with-semaglutide-in-obesity.html
Renaissance Technologies LLC Grows Position in Biomea Fusion, Inc. $BMEA
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-grows-position-in-biomea-fusion-inc-bmea-2026-08-12/
HC Wainwright Expects Stronger Earnings for Biomea Fusion
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-expects-stronger-earnings-for-biomea-fusion-2026-08-10/
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/biomea-fusion-inc-nasdaqbmea-receives-consensus-recommendation-of-moderate-buy-from-brokerages-2026-08-09/
Biomea Fusion (NASDAQ:BMEA) Issues Earnings Results
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/biomea-fusion-nasdaqbmea-issues-earnings-results-2026-08-05/
Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339675/0/en/biomea-fusion-reports-second-quarter-2026-financial-results-and-corporate-highlights.html
Biomea Fusion (BMEA) to Post Earnings on Tuesday
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/biomea-fusion-bmea-to-post-earnings-on-tuesday-2026-07-28/
Biomea Fusion Inc
July 15, 2026  |  cnn.comhttps://www.cnn.com/markets/stocks/BMEA
BMEA Share News Today
July 8, 2026  |  uk.investing.comhttps://uk.investing.com/equities/biomea-fusion-news/20
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of ...
June 5, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase-i-bmf-650-study-1036229769
Biomea Fusion Presents Promising Clinical Data for Icovamenib and Expands Phase I Study of BMF-650 at ADA 2026
June 5, 2026  |  quiverquant.comQ
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
June 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/05/3307662/0/en/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase.html
Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity
June 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/03/3305979/0/en/biomea-fusion-announces-research-collaboration-with-university-of-leicester-to-evaluate-icovamenib-in-combination-with-semaglutide-in-obesity.html
Biomea Fusion to Participate at Upcoming Investor Conferences
May 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/12/3293383/0/en/biomea-fusion-to-participate-at-upcoming-investor-conferences.html
Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights
May 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/11/3292393/0/en/biomea-fusion-reports-first-quarter-2026-financial-results-and-corporate-highlights.html
Biomea Fusion, Inc. (BMEA) Discusses Developments in Diabetes With Emphasis on Icovamenib and Clinical Trial Insights Transcript
May 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4899389-biomea-fusion-inc-bmea-discusses-developments-in-diabetes-with-emphasis-on-icovamenib-and
Citizens Initiates Coverage of Biomea Fusion (BMEA) with Market Outperform Recommendation
May 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/citizens-initiates-coverage-of-biomea-fusion-bmea-with-market-outperform-recommendation/ar-AA22tpYX
Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions
May 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/05/3288402/0/en/biomea-fusion-announces-poster-presentations-of-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions.html
Biomea Fusion, Inc. (BMEA) Discusses Top Line Results From COVALENT-112 Trial of Icovamenib in Type 1 Diabetes Transcript
April 28, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4895293-biomea-fusion-inc-bmea-discusses-top-line-results-from-covalentminus-112-trial-of-icovamenib
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of ...
April 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/biomea-fusion-announces-positive-52-213700577.html
Biomea Fusion Reports Promising 52-Week Results for Icovamenib in Phase 2 Trial for Type 1 Diabetes
April 27, 2026  |  quiverquant.comQ
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment
April 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/27/3282109/0/en/biomea-fusion-announces-positive-52-week-results-from-phase-2-covalent-112-trial-in-type-1-diabetes-showing-c-peptide-improvement-and-durability-following-12-weeks-of-icovamenib-tr.html
Biomea Fusion Announces Initiation of Phase II Trials COVALENT-211 and COVALENT-212 for Icovamenib in Type 2 Diabetes Patients
March 31, 2026  |  quiverquant.comQ
Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies
March 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/31/3265295/0/en/biomea-fusion-announces-first-patient-dosed-in-newly-initiated-phase-ii-programs-enrolling-type-2-diabetes-patients-failing-on-standard-of-care-therapies.html
Biomea Fusion, Inc. (BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes Transcript
March 31, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4887219-biomea-fusion-inc-bmea-discusses-menin-inhibition-mechanism-and-therapeutic-potential-in
Biomea Fusion, Inc. (BMEA) Discusses Phase I Data and Clinical Potential of Oral GLP-1 Receptor Antagonist for Obesity Transcript
March 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4887179-biomea-fusion-inc-bmea-discusses-phase-i-data-and-clinical-potential-of-oral-glpminus-1
Analysts Sentiment on Biomea Fusion (BMEA) Remains Strong Amid Strong Diabetes Trial Results
March 25, 2026  |  nz.finance.yahoo.comhttps://nz.finance.yahoo.com/news/analysts-sentiment-biomea-fusion-bmea-193245437.html
Biomea Fusion, Inc.: Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
March 25, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-03/68031933-biomea-fusion-inc-biomea-fusion-reports-full-year-2025-financial-results-and-corporate-highlights-399.htm
Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights
March 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/24/3261720/0/en/biomea-fusion-reports-full-year-2025-financial-results-and-corporate-highlights.html
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference
March 16, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/BMEA/pressreleases/37071019/biomea-fusion-highlights-diabetes-pipeline-at-jpm-conference/
Biomea Fusion Reports Positive 52-Week Results for Icovamenib in Type 2 Diabetes at ATTD 2026 Conference
March 14, 2026  |  quiverquant.comQ
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
March 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/14/3255846/0/en/biomea-fusion-presents-phase-ii-covalent-111-data-in-type-2-diabetes-at-the-19th-international-conference-on-advanced-technologies-treatments-for-diabetes-2026.html
Biomea Fusion to Participate at Upcoming Investor Conferences
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3240949/0/en/biomea-fusion-to-participate-at-upcoming-investor-conferences.html
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38%
January 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomea-fusion-inc-nasdaq-bmea-130912329.html
Rodman & Renshaw initiates Biomea Fusion (BMEA) at buy with $8 price target
January 19, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/rodman-renshaw-initiates-biomea-fusion-bmea-at-buy-with-8-price-target/ar-AA1UvFc4
Biomea Fusion, Inc. (BMEA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
January 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4860025-biomea-fusion-inc-bmea-presents-at-44th-annual-j-p-morgan-healthcare-conference-transcript
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
January 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/12/3216849/0/en/biomea-fusion-enters-2026-focused-on-executing-key-icovamenib-and-bmf-650-milestones.html
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/17/3206863/0/en/biomea-fusion-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference.html
H.C. Wainwright Sticks to Its Buy Rating for Biomea Fusion (BMEA)
December 17, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/BMEA/pressreleases/36524455/hc-wainwright-sticks-to-its-buy-rating-for-biomea-fusion-bmea/
Biomea Fusion (NASDAQ:BMEA) Insider Rainer Erdtmann Purchases 30,000 Shares
December 16, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-bmea-insider-buying-and-selling-2025-12-16/
Insider Spends US$99k Buying More Shares In Biomea Fusion
December 11, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/insider-spends-us-99k-buying-110051532.html
Biomea Fusion announces KOL presentation
December 10, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/biomea-fusion-announces-kol-presentation/ar-AA1S2U13
Biomea Fusion Highlights the Future of Menin Inhibitors and Icovamenib in Interview with Dr. Ralph DeFronzo at WCIRDC 2025
December 9, 2025  |  quiverquant.comQ
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
December 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/09/3202858/0/en/biomea-fusion-announces-kol-presentation-and-interview-on-menin-and-icovamenib-at-wcirdc-2025.html
Biomea Fusion stock soars after durable diabetes treatment results
December 6, 2025  |  au.investing.comhttps://au.investing.com/news/stock-market-news/biomea-fusion-stock-soars-after-durable-diabetes-treatment-results-93CH-4158038

Biomea Fusion Media Mentions By Week

Biomea Fusion Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMEA
News Sentiment
▼
0.72

0.67
▲
Average
Healthcare
News Sentiment

Biomea Fusion News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMEA Articles
This Week
▼
4

3
▲
BMEA Articles
Average Week

Biomea Fusion Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
-50%
Page Views
1,925
+10%
Get Biomea Fusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Biomea Fusion dated 8/24/2026.
From Our Partners
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...
SmartAsset | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Earth's biggest energy source: near Grand Canyon
The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...
Behind the Markets | Sponsoredtc pixel